The use of nanoparticles as contrast media in neuroimaging: A statement on toxicity

World Neurosurgery

Volumn 78, Issue 6, 2012, Pages 709-711

  Winer, Jesse L ^a   Liu, Charles Y ^a   Apuzzo, Michael L J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Contrast agent; Nanoparticles; Neuroimaging; Radiology; Safety; Super paramagnetic iron oxide; Toxicity

Indexed keywords

FERUCARBOTRAN; FERUMOXYTOL; FREE RADICAL; HEAT SHOCK PROTEIN; INTERLEUKIN 1; IRON; MATRIX METALLOPROTEINASE; NANOPARTICLE; RADIOSENSITIZING AGENT; SUPERPARAMAGNETIC IRON OXIDE; TUMOR NECROSIS FACTOR ALPHA; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ABSENCE OF SIDE EFFECTS; ACUTE TOXICITY; ALLERGENICITY; ALZHEIMER DISEASE; AMES TEST; ANAPHYLACTIC SHOCK; ATHEROSCLEROSIS; BACKACHE; BINDING AFFINITY; BIOCOMPATIBILITY; BLOOD BRAIN BARRIER; BOLUS INJECTION; CELL MIGRATION; DIAGNOSTIC IMAGING; DRUG COATING; DRUG FATALITY; DRUG SAFETY; DYSPNEA; ENDOCYTOSIS; ERYTHROPOIESIS; FATTY ACID DESATURATION; FOOD AND DRUG ADMINISTRATION; GENE ACTIVATION; HEMATOCRIT; HISTOPATHOLOGY; HUMAN; IRON BLOOD LEVEL; IRON CHELATION; IRON METABOLISM; IRON STORAGE; LIVER INJURY; LYSOSOME; MACROPHAGE; MOLECULAR INTERACTION; MUTAGENIC ACTIVITY; MUTAGENICITY; NEUROIMAGING; NEUROTOXICITY; NONHUMAN; OFF LABEL DRUG USE; OPSONIZATION; PRURITUS; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; THORAX PAIN; TUMOR MODEL; UNSPECIFIED SIDE EFFECT;

CONTRAST MEDIA; DEXTRANS; HUMANS; MAGNETITE NANOPARTICLES; NANOPARTICLES; NEUROIMAGING; RISK FACTORS;

EID: 84870543583     PISSN: 18788750     EISSN: 18788769     Source Type: Journal    
DOI: 10.1016/j.wneu.2011.08.013     Document Type: Review

References (10)

1. C. Beaumont, C. Delaby Recycling iron in normal and pathological states Sem Hematol 46 2009 328 338
2. H. Bernd, E. Kerviler, S. Gaillard, B. Bonnemain Safety and tolerability of ultrasmall superparamagnetic iron oxide contrast agent Invest Radiol 44 2009 336 342
3. Y.C. Chen, J.K. Hsiao, H.M. Liu, I.Y. Lai, M. Yao, S.C. Hsu, B.S. Ko, Y.C. Chen, C.S. Yang, D.M. Huang The inhibitory effect of superparamagnetic iron oxide nanoparticle (ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells Toxicol Appl Pharmacol 245 2010 272 279
4. M. Lévy, F. Lagarde, V.A. Maraloiu, M.G. Blanchin, F. Gendron, C. Wilhelm, F. Gazeau Degradability of superparamagnetic nanoparticles in a model of intracellular environment: follow-up of magnetic, structural and chemical properties Nanotechnology 21 2010 395103
5. L.L. Muldoon, M. Sandor, K.E. Pinkston, E.A. Neuwelt Imaging, distribution and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor Neurosurgery 57 2005 785 796
6. E.J. Park, H. Kim, Y. Kim, J. Yi, K. Choi, K. Park Inflammatory responses may be induced by a single intratracheal instillation of iron nanoparticles in mice Toxicology 275 2010 65 71
7. P.R. Ros, P.C. Freeny, S.E. Harms, S.E. Seltzer, P.L. Davis, T.W. Chan, A.E. Stillman, L.R. Muroff, V.M. Runge, M.A. Nissenbaum Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions Radiology 196 1995 481 488
8. H.S. Sharma, A. Sharma Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology Prog Brain Res 162 2007 245 273
9. P. Walczak, J. Ruiz-Cabello, D.A. Kedziorek, A.A. Gilad, S. Lin, B. Barnett, L. Qin, H. Levitsky, J.W. Bulte Magnetoelectroporation: improved labeling of neural stem cells and leukocytes for cellular magnetic resonance imaging using a single FDA-approved agent Nanomedicine 2 2006 89 94
10. R. Weissleder, D.D. Stark, B.L. Engelstad, B.R. Bacon, C.C. Compton, D.L. White, P. Jacobs, J. Lewis Superparamagnetic iron oxide: pharmacokinetics and toxicity AJR Am J Roentgenol 152 1989 167 173